Cirera S, Julve J, Ferrer I, Mainou C, Bonet R, Martin-Campos J M, González-Sastre F, Blanco-Vaca F
Servei de Bioquímica, Institut de Recerca, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Clin Chem Lab Med. 1998 Jun;36(7):443-8. doi: 10.1515/CCLM.1998.074.
We report the molecular diagnosis of a lecithin : cholesterol acyltransferase deficiency in a 12-year old proband with a high-density lipoprotein deficiency. The increased percentage of free cholesterol in plasma and high-density lipoprotein indicated an inherited lecithin : cholesterol acyltransferase deficiency as the underlying cause. This diagnosis was confirmed by a low plasma lecithin : cholesterol acyltransferase activity and a combination of genetic analyses which demonstrated compound heterozygosity for two mutations in the lecithin : cholesterol acyltransferase gene of the proband. One was a previously unreported 2 bp deletion leading to a stop signal in codon 77 and the other a point mutation causing Arg 135-->Gln transition. To our knowledge, this is the first diagnosis of lecithin : cholesterol acyltransferase deficiency in a pre-symptomatic patient. Whether the proband will develop signs of complete lecithin : cholesterol acyltransferase deficiency or the milder form (Fish Eye Disease) is uncertain, although the former possibility is more likely. The risk of premature atherosclerosis conferred by lecithin : cholesterol acyltransferase deficiency is not well established. The proband will need to be carefully monitored in the future.
我们报告了一名12岁高密度脂蛋白缺乏先证者卵磷脂胆固醇酰基转移酶缺乏症的分子诊断情况。血浆和高密度脂蛋白中游离胆固醇百分比增加表明潜在病因是遗传性卵磷脂胆固醇酰基转移酶缺乏。血浆卵磷脂胆固醇酰基转移酶活性降低以及基因分析结果证实了这一诊断,基因分析显示先证者的卵磷脂胆固醇酰基转移酶基因存在两个突变的复合杂合性。一个是先前未报道的2 bp缺失,导致第77位密码子出现终止信号,另一个是点突变,导致Arg 135→Gln转换。据我们所知,这是首例对无症状患者的卵磷脂胆固醇酰基转移酶缺乏症诊断。虽然先证者更有可能发展为完全性卵磷脂胆固醇酰基转移酶缺乏症,但不确定其是否会出现该病症体征或症状较轻的形式(鱼眼病)。卵磷脂胆固醇酰基转移酶缺乏导致的过早动脉粥样硬化风险尚未明确。未来需要对先证者进行密切监测。